Rare eye condition prompts new FDA warning on popular GLP-1 drugs
The U.S. Food and Drug Administration (FDA) is requiring makers of Ozempic, Wegovy and similar drugs to warn of a rare eye condition that can cause vision loss.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Three-layer model maps how protein-modifying enzymes may help regulate immunity
United Kingdom
-
Could eating more mushrooms help protect your brain as you age?
United Kingdom
-
Why does cancer rarely spread to the heart? Researchers develop organ-on-a-chip platform to find out
United Kingdom
-
Digitally supported care model improves serum urate target attainment in gout
United Kingdom
-
New biomarker may extend detection window for date-rape drug GHB
United Kingdom
-
Lung ultrasound predicts progression of interstitial lung abnormalities in rheumatoid arthritis
United Kingdom
-
Artery scans detect “silent atherosclerosis” in 1 in 13 adults under 30
United Kingdom
-
About half have meaningful drop in long COVID symptoms by 36 months, study finds
United Kingdom